Extensive Multiorgan and Neurological Involvement on F-18 FDG PET-CT in a Case of Rosai-Dorfman Disease

Abstract

Rosai-Dorfman disease (RDD) is a rare benign proliferative disorder. Lymph nodes are the usual and common sites of involvement. Involvement of the extranodal site is also documented in the literature. 18F-fluorodeoxyglucose positron emission tomography computed tomography (F18-FDG PET CT) is a valuable whole-body imaging modality in staging and treatment response of various lymphoproliferative and solid organ malignancy. Similarly, PET CT survey can detect the involved sites of various body systems, infective or inflammatory diseases, and provide guidance for biopsy and to reach to diagnosis. Here, we present a case of RDD, who presented with neurological manifestations and on F18-FDG PET CT, diagnosed with multiorgan involvement.

Keywords

benign proliferative disorders - F18-FDG PET CT - molecular imaging - multisystem involvement - Rosai-Dorfman disease

Authors' Contributions

P.S. contributed to collection and compilation of data whereas R.R. and H.D.S. reviewed and drafted the complied data. And T.K. gave the final approval to the data.

Publikationsverlauf

Artikel online veröffentlicht:
15. Juli 2024

• References

• 1 Abla O, Jacobsen E, Picarsic J. et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 2018; 131 (26) 2877-2890
• 2 Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969; 87 (01) 63-70
• 3 La Barge III DV, Salzman KL, Harnsberger HR. et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck. AJR Am J Roentgenol 2008; 191 (06) W299-306
• 4 Feriante J, Lee RT. Rosai-Dorfman disease: self-resolving unilateral lymphadenopathy and a brief review of literature. Case Rep Oncol Med 2018; 2018: 4869680
• 5 Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT follow-up of Rosai-Dorfman disease. Clin Nucl Med 2015; 40 (08) e420-e422
• 6 Warpe BM, More SV. Rosai-Dorfman disease: a rare clinico-pathological presentation. Australas Med J 2014; 7 (02) 68-72
• 7 Aziz M, Ray PS, Haider N, Rathore SP. Diagnosis of Rosai-Dorfman disease in elderly female on fine needle aspiration cytology: a case report. Case Rep Pathol 2012; 2012: 806130
• 8 Abrishami A, Ziaeefar P, Ebrahimi S, Khalili N, Nouralizadeh A, Farjad R. Rosai-Dorfman disease: a case report of asymptomatic isolated renal involvement. Clin Case Rep 2021; 9 (07) e04132
• 9 Au AKY, Cheng HM, Cho KY. et al. Rosai-Dorfman disease presenting as a solitary soft-tissue mass in the thigh: a case report. Hong Kong Med J 2019; 25 (02) 149-151
• 10 Garces S, Medeiros LJ, Patel KP. et al Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 2017; 30 (10) 1367-1377
• 11 Sandoval-Sus JD, Sandoval-Leon AC, Chapman JR. et al. Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature. Medicine (Baltimore) 2014; 93 (03) 165-175
• 12 Goupil de Bouillé J, de Muret A, Diot E. et al. Pulmonary manifestations revealing Rosai-Dorfman disease. Sarcoidosis Vasc Diffuse Lung Dis 2015; 32 (03) 275-277
• 13 Weerakkody Y, Worsley C. Rosai-Dorfman disease. Reference article, Radiopaedia.org. Accessed March 22, 2022 at: https://radiopaedia.org/articles/12299
• 14 Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 2011; 196 (02) W187-93
• 15 Fard-Esfahani A, Saidi B, Seyedinia S, Emami-Ardekani A, Eftekhari M. Potential role of 18F-FDG PET/CT in a case of progressive Rosai Dorfman disease. Asia Ocean J Nucl Med Biol 2021; 9 (01) 62-66
• 16 Wu YC, Hsieh TC, Kao CH. et al. A mimic of breast lymphoma: extranodal Rosai-Dorfman disease. Am J Med Sci 2010; 339 (03) 282-284
• 17 Fathala A, Edathodu J, Bakshi N. FDG PET/CT in the evaluation of a rare case of multisystem involvement in newly diagnosed Rosai-Dorfman-Destombes disease. Saudi J Med Med Sci 2021; 9 (02) 195-198
• 18 Baldi I, Belcastro M, Rossi M, Rossi A, Minacci C, Natale A. Rosai-Dorfman disease presenting as peripheral vascular insufficiency. Ann Vasc Surg 2018; 53: 267.e5-267.e9
• 19 Fard-Esfahani A, Saidi B, Seyedinia S, Emami-Ardekani A, Eftekhari M. Potential role of ¹⁸F-FDG PET/CT in a case of progressive Rosai Dorfman disease. Asia Ocean J Nucl Med Biol 2021; 9 (01) 62-66
• 20 Mahajan S, Nakajima R, Yabe M. et al. Rosai-Dorfman disease-utility of 18F-FDG PET/CT for initial evaluation and follow-up. Clin Nucl Med 2020; 45 (06) e260-e266
• 21 Pulsoni A, Anghel G, Falcucci P. et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 2002; 69 (01) 67-71
• 22 Scheel MM, Rady PL, Tyring SK, Pandya AG. Sinus histiocytosis with massive lymphadenopathy: presentation as giant granuloma annulare and detection of human herpesvirus 6. J Am Acad Dermatol 1997; 37 (04) 643-646
• 23 Aouba A, Terrier B, Vasiliu V. et al. Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach. Haematologica 2006; 91 (12) ECR52
• 24 Tasso M, Esquembre C, Blanco E, Moscardó C, Niveiro M, Payá A. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine. Pediatr Blood Cancer 2006; 47 (05) 612-615